A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivo.
Saved in:
| Title: | A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivo. |
|---|---|
| Authors: | Xie SC; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia.; Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia., Tai CW; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia., Morton CJ; Biomedical Manufacturing Program, CSIRO, Clayton South, Victoria, Australia., Ma L; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America., Huang SC; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America., Wittlin S; Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; University of Basel, Basel, Switzerland., Du Y; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia., Hu Y; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America., Dogovski C; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia., Salimimarand M; School of Chemistry, The University of Melbourne, Melbourne, Victoria, Australia., Griffin R; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America., England D; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America., de la Cruz E; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America., Deni I; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Medical Center, New York, New York, United States of America.; Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, United States of America., Yeo T; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Medical Center, New York, New York, United States of America.; Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, United States of America., Burkhard AY; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Medical Center, New York, New York, United States of America.; Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, United States of America., Striepen J; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Medical Center, New York, New York, United States of America.; Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, United States of America., Schindler KA; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Medical Center, New York, New York, United States of America.; Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, United States of America., Crespo B; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Gamo FJ; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Khandokar Y; ANSTO-Australian Synchrotron, Clayton, Victoria, Australia., Hutton CA; School of Chemistry, The University of Melbourne, Melbourne, Victoria, Australia., Rabie T; Department of Biochemistry, Genetics and Microbiology, University of Pretoria Institute for Sustainable Malaria Control, University of Pretoria, Hatfield, South Africa., Birkholtz LM; Department of Biochemistry, Genetics and Microbiology, University of Pretoria Institute for Sustainable Malaria Control, University of Pretoria, Hatfield, South Africa., Famodimu MT; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Delves MJ; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Bolsher J; TropIQ Health Sciences, Nijmegen, The Netherlands., Koolen KMJ; TropIQ Health Sciences, Nijmegen, The Netherlands., van der Laak R; TropIQ Health Sciences, Nijmegen, The Netherlands., Aguiar ACC; Federal University of São Paulo, São Paulo, São Paulo, Brazil., Pereira DB; Research Center for Tropical Medicine of Rondonia, Porto Velho, Brazil., Guido RVC; Sao Carlos Institute of Physics, University of São Paulo, São Carlos, Brazil., Creek DJ; Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia., Fidock DA; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Medical Center, New York, New York, United States of America.; Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, United States of America.; Division of Infectious Diseases, Department of Medicine, Columbia University Medical Center, New York, New York, United States of America., Dick LR; Seofon Consulting, Natick, Massachusetts, United States of America., Brand SL; Medicines for Malaria Venture, Geneva, Switzerland., Gould AE; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America., Langston S; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America., Griffin MDW; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia., Tilley L; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia. |
| Source: | PLoS pathogens [PLoS Pathog] 2024 Dec 09; Vol. 20 (12), pp. e1012429. Date of Electronic Publication: 2024 Dec 09 (Print Publication: 2024). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39652589 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivo. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Xie+SC%22">Xie SC</searchLink>; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia.; Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Tai+CW%22">Tai CW</searchLink>; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Morton+CJ%22">Morton CJ</searchLink>; Biomedical Manufacturing Program, CSIRO, Clayton South, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Ma+L%22">Ma L</searchLink>; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Huang+SC%22">Huang SC</searchLink>; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Wittlin+S%22">Wittlin S</searchLink>; Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Du+Y%22">Du Y</searchLink>; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Hu+Y%22">Hu Y</searchLink>; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Dogovski+C%22">Dogovski C</searchLink>; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Salimimarand+M%22">Salimimarand M</searchLink>; School of Chemistry, The University of Melbourne, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Griffin+R%22">Griffin R</searchLink>; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22England+D%22">England D</searchLink>; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22de+la+Cruz+E%22">de la Cruz E</searchLink>; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Deni+I%22">Deni I</searchLink>; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Medical Center, New York, New York, United States of America.; Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Yeo+T%22">Yeo T</searchLink>; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Medical Center, New York, New York, United States of America.; Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Burkhard+AY%22">Burkhard AY</searchLink>; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Medical Center, New York, New York, United States of America.; Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Striepen+J%22">Striepen J</searchLink>; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Medical Center, New York, New York, United States of America.; Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Schindler+KA%22">Schindler KA</searchLink>; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Medical Center, New York, New York, United States of America.; Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Crespo+B%22">Crespo B</searchLink>; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gamo+FJ%22">Gamo FJ</searchLink>; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Khandokar+Y%22">Khandokar Y</searchLink>; ANSTO-Australian Synchrotron, Clayton, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Hutton+CA%22">Hutton CA</searchLink>; School of Chemistry, The University of Melbourne, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Rabie+T%22">Rabie T</searchLink>; Department of Biochemistry, Genetics and Microbiology, University of Pretoria Institute for Sustainable Malaria Control, University of Pretoria, Hatfield, South Africa.<br /><searchLink fieldCode="AU" term="%22Birkholtz+LM%22">Birkholtz LM</searchLink>; Department of Biochemistry, Genetics and Microbiology, University of Pretoria Institute for Sustainable Malaria Control, University of Pretoria, Hatfield, South Africa.<br /><searchLink fieldCode="AU" term="%22Famodimu+MT%22">Famodimu MT</searchLink>; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Delves+MJ%22">Delves MJ</searchLink>; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bolsher+J%22">Bolsher J</searchLink>; TropIQ Health Sciences, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Koolen+KMJ%22">Koolen KMJ</searchLink>; TropIQ Health Sciences, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Laak+R%22">van der Laak R</searchLink>; TropIQ Health Sciences, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Aguiar+ACC%22">Aguiar ACC</searchLink>; Federal University of São Paulo, São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Pereira+DB%22">Pereira DB</searchLink>; Research Center for Tropical Medicine of Rondonia, Porto Velho, Brazil.<br /><searchLink fieldCode="AU" term="%22Guido+RVC%22">Guido RVC</searchLink>; Sao Carlos Institute of Physics, University of São Paulo, São Carlos, Brazil.<br /><searchLink fieldCode="AU" term="%22Creek+DJ%22">Creek DJ</searchLink>; Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Fidock+DA%22">Fidock DA</searchLink>; Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Medical Center, New York, New York, United States of America.; Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, United States of America.; Division of Infectious Diseases, Department of Medicine, Columbia University Medical Center, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Dick+LR%22">Dick LR</searchLink>; Seofon Consulting, Natick, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Brand+SL%22">Brand SL</searchLink>; Medicines for Malaria Venture, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gould+AE%22">Gould AE</searchLink>; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Langston+S%22">Langston S</searchLink>; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Griffin+MDW%22">Griffin MDW</searchLink>; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Tilley+L%22">Tilley L</searchLink>; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101238921%22">PLoS pathogens</searchLink> [PLoS Pathog] 2024 Dec 09; Vol. 20 (12), pp. e1012429. <i>Date of Electronic Publication: </i>2024 Dec 09 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238921 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537366%22">15537366 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Pathog <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39652589 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.ppat.1012429 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1012429 Titles: – TitleFull: A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivo. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Xie SC – PersonEntity: Name: NameFull: Tai CW – PersonEntity: Name: NameFull: Morton CJ – PersonEntity: Name: NameFull: Ma L – PersonEntity: Name: NameFull: Huang SC – PersonEntity: Name: NameFull: Wittlin S – PersonEntity: Name: NameFull: Du Y – PersonEntity: Name: NameFull: Hu Y – PersonEntity: Name: NameFull: Dogovski C – PersonEntity: Name: NameFull: Salimimarand M – PersonEntity: Name: NameFull: Griffin R – PersonEntity: Name: NameFull: England D – PersonEntity: Name: NameFull: de la Cruz E – PersonEntity: Name: NameFull: Deni I – PersonEntity: Name: NameFull: Yeo T – PersonEntity: Name: NameFull: Burkhard AY – PersonEntity: Name: NameFull: Striepen J – PersonEntity: Name: NameFull: Schindler KA – PersonEntity: Name: NameFull: Crespo B – PersonEntity: Name: NameFull: Gamo FJ – PersonEntity: Name: NameFull: Khandokar Y – PersonEntity: Name: NameFull: Hutton CA – PersonEntity: Name: NameFull: Rabie T – PersonEntity: Name: NameFull: Birkholtz LM – PersonEntity: Name: NameFull: Famodimu MT – PersonEntity: Name: NameFull: Delves MJ – PersonEntity: Name: NameFull: Bolsher J – PersonEntity: Name: NameFull: Koolen KMJ – PersonEntity: Name: NameFull: van der Laak R – PersonEntity: Name: NameFull: Aguiar ACC – PersonEntity: Name: NameFull: Pereira DB – PersonEntity: Name: NameFull: Guido RVC – PersonEntity: Name: NameFull: Creek DJ – PersonEntity: Name: NameFull: Fidock DA – PersonEntity: Name: NameFull: Dick LR – PersonEntity: Name: NameFull: Brand SL – PersonEntity: Name: NameFull: Gould AE – PersonEntity: Name: NameFull: Langston S – PersonEntity: Name: NameFull: Griffin MDW – PersonEntity: Name: NameFull: Tilley L IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 12 Text: 2024 Dec 09 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1553-7374 Numbering: – Type: volume Value: 20 – Type: issue Value: 12 Titles: – TitleFull: PLoS pathogens Type: main |
| ResultId | 1 |